|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 47/28 | |
| A61K 31/17 | |||
| A61P 35/00 | |||
| A61K 31/4166 | |||
| A61K 31/4184 |
| (11) | Number of the document | 2739153 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12846720.6 |
| Date of filing the European patent application | 2012-07-27 | |
| (97) | Date of publication of the European application | 2014-06-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/048471 |
| Date | 2012-07-27 |
| (87) | Number | WO 2013/066440 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161513361 P | 2011-07-29 | US |
| (72) |
PROTTER, Andrew A., US
RICHER, Jennifer, US
COCHRANE, Dawn, US
|
| (73) |
The Regents of the University of Colorado, a body corporate,
1800 Grant Street, 8th Floor, Denver, CO 80203,
US
Medivation Prostate Therapeutics LLC, 525 Market Street 36th Floor, San Francisco, CA 94105, US |
| (54) | TREATMENT OF BREAST CANCER |
| TREATMENT OF BREAST CANCER |